US · Consumer Cyclical · Specialty Retail
EPS came in at 0.62 against a street estimate of 0.24 — a beat of 158.3%.
Analysts rate Bath & Body Works Inc. a buy (11 buy, 8 hold, 1 sell out of 20) with an average price target of $24.06.
CONFIDENT Bath & Body Works beat Q2 expectations with 2.3% sales decline (vs. guidance -5% to -3%) and $0.62 EPS (vs. $0.20–$0.25). Consumer-first strategy showing early wins: digital returned to growth, Fusion launch exceeded sales targets, Amazon tripled, Ulta partnership launched. Raising FY26 EPS guidance to $2.60–$2.80; narrowing sales to -4% to -2.5%. Q2 FY26 Digital returned to growth (first time since 2021) improving 4 percentage points sequentially from Q1, with increases in new, existing, and reactivated customers. International retail up 9% despite Middle East conflict; Brazil launch in July performing well. Analysts pressed on Q3 sales deceleration despite Q2 beat and easing comps; management emphasized transformation timeline, traffic headwinds, and disciplined promotional stance. Fusion playbook became centerpiece: strong product innovation, franchise management, coordinate…
Full summary in the app.
| Fund | Stake |
|---|---|
| FMR Inc | 10.36% |
| BlackRock Inc | 9.59% |
| Vanguard Portfolio Management, LLC | 7.45% |
| AQR Capital Management LLC | 5.48% |
| Vanguard Capital Management, LLC | 4.54% |
| D. E. Shaw & Co LP | 3.83% |
| State Street Corp | 3.44% |
| AllianceBernstein L.P. | 2.85% |
| Document | Date |
|---|---|
| Quarterly report · Q3 FY2027 BATH & BODY WORKS, INC. — Q2 2026 10-Q SUMMARY --- HEADLINE NUMBERS • Net Sales Q2 2026: $1,514 million (down 2.3% vs. Q2 2025: $1,549 million) • N | 2026-08-26 |
| Results announced · Q3 FY2027 BATH & BODY WORKS, INC. - Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Q2 2026 net sales: $1,514 million, down 2.3% vs $1,549 million in Q2 2025 • Ea | 2026-08-26 |
| Reg FD disclosure · Q2 FY2027 BATH & BODY WORKS, INC. – FORM 8-K SUMMARY HEADLINE NUMBERS • Company announced partial redemption of $250 million aggregate principal amount of 7.5 | 2026-07-20 |
| Shareholder vote results · Q2 FY2027 BATH & BODY WORKS, INC. (BBWI) – 8-K FILING SUMMARY HEADLINE NUMBERS • Annual Meeting Date: June 11, 2026 • Total Shares Present/Represented: 180,87 | 2026-06-15 |
| Quarterly report · Q2 FY2027 BATH & BODY WORKS, INC. — Q1 2026 FINANCIAL SUMMARY HEADLINE NUMBERS • Net Sales Q1 2026: $1,378 million (down from $1,424 million in Q1 2025, -3.2% | 2026-05-27 |
| Results announced · Q2 FY2027 BATH & BODY WORKS, INC. – Q1 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Q1 2026 net sales: $1,378 million, down 3% versus Q1 2025 ($1,424 million) • R | 2026-05-27 |
| Proxy statement · Q2 FY2027 BATH & BODY WORKS, INC. PROXY STATEMENT SUMMARY WHAT SHAREHOLDERS ARE VOTING ON • Item 1: Election of 10 Directors – Vote standard: majority of vote | 2026-04-28 |
| Annual report FY2026 BATH & BODY WORKS, INC. – FISCAL YEAR 2025 (ENDED JANUARY 31, 2026) HEADLINE NUMBERS • Market capitalization: Approximately $5.8 billion as of last | 2026-03-12 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.20 / share ex-date Aug 21, 2026 · pay Sep 4, 2026 | 2026-08-21 |
| Dividend | $0.20 / share ex-date Jun 5, 2026 · pay Jun 19, 2026 | 2026-06-05 |
| Dividend | $0.20 / share ex-date Feb 20, 2026 · pay Mar 6, 2026 | 2026-02-20 |
| Dividend | $0.20 / share ex-date Nov 21, 2025 · pay Dec 5, 2025 | 2025-11-21 |
| Dividend | $0.20 / share ex-date Aug 22, 2025 · pay Sep 5, 2025 | 2025-08-22 |
| Announcement | Date |
|---|---|
| Q2 2026 results issued with Q3 and full-year 2026 earnings guidance updated Bath Body Works, Inc. issued a press release on August 26, 2026, reporting unaudited financial results for the second quarter of 2026 and providing earnings guidance for Q3 2026 and updated | 2026-08-26 |
| Q4 2025 results and Q1 2026 full-year earnings guidance issued Bath Body Works issued an 8-K on March 4, 2026, disclosing its fourth quarter and full-year 2025 financial results along with guidance for Q1 2026 and full-year 2026. However, this filing it | 2026-03-04 |
| Q3 2025 results and updated full-year 2025 earnings guidance issued Bath Body Works issued an 8-K on November 20, 2025, disclosing its Q3 2025 unaudited financial results and providing updated earnings guidance for Q4 2025 and full-year 2025. However, the ac | 2025-11-20 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Bath & Body Works Inc. — free to start.
Google PlayApp StoreData updated 2026-09-18.